POSSIBLE POTENTIATION OF WARFARIN BY FLUCONAZOLE

被引:25
作者
SEATON, TL
CELUM, CL
BLACK, DJ
机构
[1] UNIV WASHINGTON,SCH PHARM,DEPT PHARM,SC-69,SEATTLE,WA 98195
[2] UNIV WASHINGTON,SCH PHARM,DEPT PHARM PRACTICE,SEATTLE,WA 98195
[3] UNIV WASHINGTON,SCH PHARM,DEPT FAMILY MED,SEATTLE,WA 98195
[4] UNIV WASHINGTON,DEPT MED,DIV NEUROSURG,SEATTLE,WA 98195
来源
DICP-THE ANNALS OF PHARMACOTHERAPY | 1990年 / 24卷 / 12期
关键词
D O I
10.1177/106002809002401207
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Fluconazole, a new triazole antifungal agent, interacts with a number of drugs. Only one study to date has examined the potentiation of warfarin's anticoagulant effect by fluconazole. To our knowledge, this is the first published case report of this interaction in the clinical setting. The patient had received a stable dosage regimen of warfarin for a number of months. Fluconazole 100 mg bid was added for a candidal wound infection. The prothrombin time increased from 19 to 65 seconds eight days later and the patient experienced a gastrointestinal bleeding episode. Fresh-frozen plasma was administered and warfarin was discontinued while the patient completed a planned 21-day course of fluconazole. The patient eventually resumed the original warfarin dosage with stable coagulation parameters. Until the influence of fluconazole on the anticoagulant effect of warfarin is studied in further detail, careful monitoring of coagulation parameters is recommended for all patients receiving the combination.
引用
收藏
页码:1177 / 1178
页数:2
相关论文
empty
未找到相关数据